The Lithuanian office of Sorainen has advised Koinveticinis Fondas on its investment in Ligence, a Lithuanian startup developing an automated cardiac ultrasound diagnostic solution based on artificial intelligence.
According to Sorainen, "the product, developed by a team of eight doctors, performs heart measurements and helps diagnose heart changes. Both developers and investors are confident that the tool, which facilitates the examination of cardiac ultrasound, will contribute to the fight against COVID-19."
Koinvesticinis Fondas, Vladas Lasas, and other members of the LitBan business network invested EUR 360,000 in the startup.
Sorainen's team consisted of Partner Mantas Petkevicius and Senior Associate Vytautas Sabalys.
Sorainen did not reply to our inquiry on the matter.